skip to main content
Show Results with:

Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz

AIDS Care, 01 June 2011, Vol.23(6), pp.705-713 [Peer Reviewed Journal]

No full-text

Searching Remote Databases, Please Wait